Vaxxinity, Inc.

Vaxxinity, Inc. (VAXX) priced its initial public offering on Nov 12, 2021 at $13.00 per share, raising $78M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $1.44B. BofA Securities was lead-left underwriter, joined by Jefferies and Evercore ISI. Cravath advised the company and Kirkland & Ellis advised the underwriters.

Vaxxinity, Inc. is a biotechnology company developing synthetic peptide vaccines for chronic diseases through its Vaxxine Platform. It aims to offer an alternative to monoclonal antibody drugs that carry high costs and cumbersome administration.

Status

IPO

Ticker

VAXX

Exchange

Nasdaq Global Market

Priced

Nov 12, 2021

IPO price

$13.00

Raised

$78M

Market cap at IPO price

$1.44B

First filed

Oct 8, 2021

Underwriters

BofA Securities, Jefferies and Evercore ISI

Company counsel

Cravath

Underwriters' counsel

Kirkland & Ellis

Sector

Biotech & pharma

Country / state

FL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.